Taiwan FDA registration c2a91b15605f99f58b33deaf8b5ad536
Lumipulse BNP Controls
TW: 錄秘帕斯B型利鈉尿胜品管液
Taiwan·Risk Class 2·MD·FUJIREBIO INC., HACHIOJI FACILITY·Registered Dec 27, 2018 – Dec 27, 2028ActiveRegistration details
- Analysis ID
- c2a91b15605f99f58b33deaf8b5ad536
- License Form
- Ministry of Health Medical Device Import No. 031991
- Customs Code
- DHA05603199102
Company information
- Manufacturer
- FUJIREBIO INC., HACHIOJI FACILITY
- Manufacturer Country
- Japan
- Authorized Representative
- Grand Marquis IVD CO., LTD.
Product details
- Intended Use
- This product is used in Lumipulse G1200 analyzer, with Lumipulse BNP test reagent to monitor the precision of experimental test procedures when testing human type B natriuretic urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 27, 2018
- Expiry Date
- Dec 27, 2028
About this record
Access comprehensive regulatory information for Lumipulse BNP Controls in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c2a91b15605f99f58b33deaf8b5ad536 and manufactured by FUJIREBIO INC., HACHIOJI FACILITY. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices